Login to Your Account

Financings Roundup

Resolvyx Adds $25M to Move First Resolvin Drugs into Clinic

By Jennifer Boggs

Wednesday, April 23, 2008
Gearing up to move its first two drug candidates into the clinic this year, Resolvyx Pharmaceuticals Inc. padded its bank account with a $25 million Series B round from new and existing investors. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription